TipRanks
Go Ultimate55% OFF

CanSino Biologics, Inc. Class H (6185) Stock Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

6185 Analyst Ratings

Moderate Buy
2Ratings
2Buy0Hold0Sell
Based on 2 analysts giving stock ratings to CanSino Biologics, Inc. Class H in the past 3 months

6185 Stock 12 Month Forecast

HKD 49.60▲(92.40% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for CanSino Biologics, Inc. Class H in the last 3 months. The average price target is HKD 49.60 with a high forecast of HKD 53.20 and a low forecast of HKD 46.00. The average price target represents a 92.40% change from the last price of HKD 25.78.
Highest Price TargetHKD 53.20Average Price TargetHKD 49.60Lowest Price TargetHKD 46.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for HK:6185
Price TargetFollowArticle
Citic Securities Analyst forecast on HK:6185Unknown AnalystNot RankedCitic SecuritiesHKD 46buy78.43%UpsideReiterated09/08/26
CLSA Analyst forecast on HK:6185Unknown AnalystNot RankedCLSAHKD 53.20buy106.36%UpsideReiterated08/26/26
UBS Analyst forecast on HK:6185Unknown AnalystNot RankedUBSHKD 52.40buy103.26%UpsideReiterated06/25/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AORTArtivion
MDWDMediwound
IMUXImmunic
RZLTRezolute
DFTXDefinium Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering CanSino Biologics, Inc. Class H

3 Months
Success Rate0/2 ratings generated profit
0%
Average Return
-22.30%

Copying Anita Wei's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -22.30% per trade.

1 Year
Success Rate0/2 ratings generated profit
0%
Average Return
-43.30%

Copying Anita Wei's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -43.30% per trade.

2 Years
Success Rate0/2 ratings generated profit
0%
Average Return
-44.45%

Copying Anita Wei's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -44.45% per trade.

6185 Analyst Recommendation Trends

00.511.52Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
Monthly rating counts for 6185
RatingMay 26Jun 26Jul 26Aug 26Sep 26
Strong Buy11111
Buy00111
Hold00000
Sell00000
Strong Sell00000
total11222

In the current month, 6185 has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 6185 average Analyst price target in the past 3 months is 49.60.

6185 Financial Forecast

HKD -2HKD -1.25HKD -0.5HKD 0.25HKD 1Q1 2026Q3 2026Q4 2026
HighHKD 0.38
ConsensusHKD 0.38
LowHKD 0.38

6185 Earnings Forecast

Next quarter’s earnings estimate for 6185 is HKD 0.38 with a range of HKD 0.38 to HKD 0.38. The previous quarter’s EPS was HKD 0.08. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

HKD 214.7MHKD 326.6MHKD 438.5MHKD 550.4MHKD 662.3MQ1 2026Q3 2026Q4 2026
HighHKD 662M
ConsensusHKD 662M
LowHKD 662M

6185 Sales Forecast

Next quarter’s sales forecast for 6185 is HKD 662.27M with a range of HKD 662.27M to HKD 662.27M. The previous quarter’s sales results were HKD 386.75M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

6185 Stock Forecast FAQ

What is HK:6185’s average 12-month price target, according to analysts?
Based on analyst ratings, CanSino Biologics, Inc. Class H’s 12-month average price target is HK$49.60.
What is HK:6185’s upside potential, based on the analysts’ average price target?
CanSino Biologics, Inc. Class H has 92.40% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CanSino Biologics, Inc. Class H a Buy, Sell or Hold?
CanSino Biologics, Inc. Class H has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is CanSino Biologics, Inc. Class H’s share price target?
The average share price target for CanSino Biologics, Inc. Class H is HK$49.60. This is based on 2 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is HK$53.20, and the lowest forecast is HK$46.00. The average share price target represents a 92.40% increase from the current price of HK$25.78.
What do analysts say about CanSino Biologics, Inc. Class H?
CanSino Biologics, Inc. Class H’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Street analysts.
How can I buy shares of CanSino Biologics, Inc. Class H?
To buy shares of HK:6185, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.